Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer--safety, efficacy and quality of life (Q46613445)
Jump to navigation
Jump to search
scientific article published on 20 July 2005
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer--safety, efficacy and quality of life |
scientific article published on 20 July 2005 |
Statements
1 reference
Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer--safety, efficacy and quality of life (English)
1 reference
Daniel K H Tong
1 reference
Carter W N Cheng
1 reference
See Ching Chan
1 reference
Lai Ngor Wong
1 reference
Louis W C Chow
1 reference
20 July 2005
1 reference
1 reference
68
1 reference
4-6
1 reference
520-525
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference